
OncoBytes Microlearning Pathways: New Directions in Triple-Negative Breast Cancer – Practice-Ready Updates and Expert Insights Into Recent Therapeutic Breakthroughs
This resource center is supported by an educational grant from Gilead Sciences, Inc.
Welcome to this OncoByte Personalized Learning Pathway!
Each OncoByte video consists of a 5-minute presentation delivered by our expert faculty on practice-ready updates in triple-negative breast cancer (TNBC) or a 5- or 10-minute panel discussion where our expert faculty will help you synthesize the latest information and data on TROP2-targeted ADCs to help guide your incorporation of these novel treatments into everyday practice.
For each module, select at least 3 videos to build a custom microlearning program focused on your interests.